Shares of NLC India rose 12.2% to Rs 237.05 after posting a record Q3 PAT of Rs 2,245 crore, marking a 28% YoY growth. The company also declared an interim dividend of Rs 1.50 per share, with February 7 as the record date for eligibility and payments to be made by March 4.
Joe Biden has signed with Creative Artists Agency in Los Angeles. This marks a significant step in his post-presidency career. Biden, who previously collaborated with CAA, aims to continue his public service legacy. The agency also represents notable figures like Barack and Michelle Obama. While Biden's future projects are unknown, his partnership with CAA signifies ongoing influence.
Shares of Vodafone Idea surged by as much as 5.7% on Tuesday, reaching Rs 9.6 on the BSE, after Finance Secretary Tuhin Kanta Pandey hinted that the government is considering a proposal to waive 50% of the interest and 100% of the penalties and interest on penalties, which make up a significant portion of the adjusted gross revenue (AGR) dues levied on telecom companies such as Vodafone Idea and Bharti Airtel.
Samvardhana Motherson International shares surged 9% to Rs 142.15 following Trumps decision to pause tariffs on Mexico and Canada. The company, reliant on exports (80% of revenue), was impacted by tariff uncertainty. Additionally, a joint venture with Hamakyorex of Japan boosted market sentiment. Despite a 10.43% YTD loss, the stock has gained 20.08% over the past year.
China countered President Donald Trumps across-the-board tariffs on Chinese products with tariffs on select U.S. imports, as well as announcing an antitrust investigation into Google.
Prashant Khemka, Founder of White Oak Capital Management, anticipates a shift in performance between cyclical and defensive stocks. The Budget may reinforce this phenomenon. Khemka advises maintaining a balanced portfolio, emphasizing stock picking over top-down calls. He also notes the potential positive impact of income tax savings on demand and broad sectoral benefits.
Gland Pharma share price: Revenue from operations fell 10% year-on-year to Rs 1,384 crore. EBITDA increased by 1% year-on-year to Rs 360 crore, with margins improving by 300 basis points to 26%. R&D expenses were Rs 43.7 crore, making up 4.3% of the revenue.
Gold prices remain near record highs as investors worry about potential inflation due to President Trump's tariffs on Canada, China, and Mexico. Trump has suspended tariffs on Mexico and Canada for 30 days, while tariffs on Chinese goods proceed. Economic data later in the week will offer further insight into the economy's strength.
Dr Agarwal's Health Care's upcoming listing worries investors due to a discounted grey market premium and muted subscription. Despite being India's largest eye care chain, with a 25% market share in FY24, and significant revenue and efficiency growth, market conditions appear challenging. Analysts recommend a long-term investment view for potential gains.